Trials / Unknown
UnknownNCT03782675
Air Barrier System for the Reduction of Airborne Colony-forming Units During Total Shoulder Arthroplasty
Air Barrier System for the Reduction of Airborne Particulate and Colony-forming Units (CFU) During Total Shoulder Arthroplasty.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Nimbic Systems, LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to determine whether the Air Barrier System device reduces airborne colony-forming units (e.g., bacteria) present at a surgery site during total shoulder arthroplasty surgeries.
Detailed description
The Air Barrier System (ABS) is a device that uses localized clean air flow to shield a surgery site from ambient airborne contamination. This study examines the hypothesis that the ABS can reduce the presence of airborne CFU and particles at the surgery site during total arthroplasty surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Control | The Air Barrier System will be deployed onto the surgical field, but the airflow will not be activated, so this is a sham control comparator. |
| DEVICE | Air Barrier System | The Air Barrier System is a device that uses localized clean air flow to shield a surgery site from ambient airborne microorganisms that are shed into the air from people present in the operating room. |
Timeline
- Start date
- 2019-02-01
- Primary completion
- 2019-05-01
- Completion
- 2019-07-01
- First posted
- 2018-12-20
- Last updated
- 2018-12-20
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03782675. Inclusion in this directory is not an endorsement.